These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12189927)

  • 1. [How to treat effectively hypertensive patient with overactivity of sympathetic system?].
    Wańkowicz Z
    Pol Arch Med Wewn; 2002 Apr; 107(4):349-59. PubMed ID: 12189927
    [No Abstract]   [Full Text] [Related]  

  • 2. Sympathetic overactivity and arterial hypertension in renal failure.
    Orth SR; Amann K; Strojek K; Ritz E
    Nephrol Dial Transplant; 2001; 16 Suppl 1():67-9. PubMed ID: 11369825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic overactivity in hypertensive patients with chronic renal disease.
    Remuzzi G
    N Engl J Med; 1999 Apr; 340(17):1360-1. PubMed ID: 10219074
    [No Abstract]   [Full Text] [Related]  

  • 4. Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension?
    Biaggioni I
    Hypertension; 2008 Feb; 51(2):168-71. PubMed ID: 18086947
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of antihypertensive agents from various pharmacological groups on blood pressure reaction during stress-testing. Part I. Comparative characteristics of medications, exerting effect of sympathoadrenal block].
    Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA; Savel'eva SA
    Kardiologiia; 2008; 48(3):44-51. PubMed ID: 18429756
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renal sequelae of sympathetic hyperactivity].
    Watschinger B; Habicht A
    Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546
    [No Abstract]   [Full Text] [Related]  

  • 7. New drugs for the treatment of hypertension.
    Mancia G; Stella ML; Grassi G
    Curr Opin Cardiol; 1999 Sep; 14(5):375-80. PubMed ID: 10500899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central nervous system as a target for the new antihypertensive agents].
    Nurminen ML
    Duodecim; 1999; 115(20):2267-73. PubMed ID: 11973931
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurogenic factors in hypertension: therapeutic implications.
    Campese VM
    Ann Ital Med Int; 1994 Oct; 9 Suppl():39S-43S. PubMed ID: 7857755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New central agents in the treatment of arterial hypertension].
    Robles NR
    An Med Interna; 1999 Oct; 16(10):495-7. PubMed ID: 10603665
    [No Abstract]   [Full Text] [Related]  

  • 12. Cause and consequences of sympathetic hyperactivity in chronic kidney disease.
    Kotanko P
    Blood Purif; 2006; 24(1):95-9. PubMed ID: 16361848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Centrally acting antihypertensives: not obsolete after all.
    Schachter M
    Int J Clin Pract; 1998; 52(3):192-5. PubMed ID: 9684437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of essential arterial hypertension. IV. Drugs with peripheral sympathetic action].
    Fossati C
    Clin Ter; 1980 May; 93(4):457-79. PubMed ID: 6106537
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-blockers as sub-optimal treatment for hypertension: time for first-line therapy revision?
    Narkiewicz K; Kjeldsen SE; Oparil S; Hedner T
    Blood Press; 2006; 15(6):323-4. PubMed ID: 17472021
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antihypertensive drugs for therapy of hypertension due to long-term hemodialysis].
    Kikawada R; Tsuyusaki T
    Nihon Rinsho; 1991 Dec; 49 Suppl():702-8. PubMed ID: 1687286
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of sympathetic overactivity in patients with chronic renal failure: a role for chemoreflex activation?
    Hausberg M; Grassi G
    J Hypertens; 2007 Jan; 25(1):47-9. PubMed ID: 17143171
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of clonidine in patients with essential hypertension with neurovascular contact of the rostral ventrolateral medulla.
    Sakuma T; Morimoto S; Aota Y; Takahashi N; Toyoda N; Kosaki A; Maehara M; Tanigawa N; Ikeda K; Sawada S; Iwasaka T
    Hypertens Res; 2010 Jun; 33(6):633-7. PubMed ID: 20379192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic overactivity as a cause of hypertension in chronic renal failure.
    Augustyniak RA; Tuncel M; Zhang W; Toto RD; Victor RG
    J Hypertens; 2002 Jan; 20(1):3-9. PubMed ID: 11791019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure.
    Shibao C; Gamboa A; Abraham R; Raj SR; Diedrich A; Black B; Robertson D; Biaggioni I
    Hypertension; 2006 Mar; 47(3):522-6. PubMed ID: 16391172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.